Faiez Zannad at at 2nd Human and Veterinary Crosstalk Symposium on Aldosterone, Bordeaux 2011
MD, PhD, Professor of Therapeutics and Cardiology, Director, Clinical Investigation Centre, INSERM, Head of Heart Failure and Hypertension Unit, Department of Cardiology, CHU and University Henri Poincaré, Nancy, France.  

Contact: f.zannad@chu-nancy.fr

Faiez Zannad is Professor of Therapeutics and Cardiology. He is at the Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU) of Nancy since 1995.

He entered the European Society of Cardiology (ESC) in 1996 and is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension. As the Coordinator of French Cardiovascular Clinical Investigation Centres, he has participated in various famous large scale trials in human cardiology such as RALES,VALIANT, CIBIS, CAPRICORN, EPHESUS or EMPHASIS-HF. In these trials, he has been involved either as a member of the Steering Committees or in the Protocol Writing Groups.

He is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT)and on Biomarkers in Heart Failure.